Episode Details
Back to EpisodesNew JAK City, PE Exit Struggles, CBD for Dogs Inches Forward, PetcoLove 4M
Episode 140
Published 8 months, 1 week ago
Description
Second week of March, what'd you miss in vet med?
- FDA approves Merck's NUMELVI — first second-gen JAK inhibitor for dogs
- PE firms struggling to exit pandemic-era vet deals (Encore, CareVet, and Blue River hit the market)
- InnoCan gets third FDA fee waiver for CBD pain injection in dogs
- PetSmart + Healthy Paws expand insurance partnership
- Petco Love hits 4 million free vaccines
Helpful links: